[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Mebendazole Industry Research Report 2023

August 2023 | 93 pages | ID: MCF57FAE7C2EEN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.

Highlights

The global Mebendazole market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.

Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.

Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mebendazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mebendazole.

The Mebendazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Mebendazole market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mebendazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Johnson & Johnson
  • Amneal Pharmaceuticals
  • Cadila Pharmaceuticals
  • Eipico
  • Esteve Pharmaceuticals
  • Tenry
Product Type Insights

Global markets are presented by Mebendazole type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Mebendazole are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Mebendazole segment by Type
  • Tablet
  • Oral Suspension
Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Mebendazole market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Mebendazole market.

Mebendazole segment by Application
  • Below 2 Years Old
  • Above 2 Years Old
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Mebendazole market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebendazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Mebendazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Mebendazole industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebendazole.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Mebendazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Mebendazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Mebendazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions
  • Which product segment grabbed the largest share in the Product Name market?
  • How is the competitive scenario of the Product Name market?
  • Which are the key factors aiding the Product Name market growth?
  • Which are the prominent players in the Product Name market?
  • Which region holds the maximum share in the Product Name market?
  • What will be the CAGR of the Product Name market during the forecast period?
  • Which application segment emerged as the leading segment in the Product Name market?
  • What key trends are likely to emerge in the Product Name market in the coming years?
  • What will be the Product Name market size by 2028?
  • Which company held the largest share in the Product Name market?
LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Mebendazole Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Mebendazole Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Mebendazole Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Mebendazole Revenue of Manufacturers (2018-2023)
Table 9. Global Mebendazole Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Mebendazole Average Price (USD/Unit) of Manufacturers (2018-2023)
Table 11. Global Mebendazole Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Mebendazole, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mebendazole by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Johnson & Johnson Company Information
Table 17. Johnson & Johnson Business Overview
Table 18. Johnson & Johnson Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 19. Johnson & Johnson Mebendazole Product Portfolio
Table 20. Johnson & Johnson Recent Developments
Table 21. Amneal Pharmaceuticals Company Information
Table 22. Amneal Pharmaceuticals Business Overview
Table 23. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 24. Amneal Pharmaceuticals Mebendazole Product Portfolio
Table 25. Amneal Pharmaceuticals Recent Developments
Table 26. Cadila Pharmaceuticals Company Information
Table 27. Cadila Pharmaceuticals Business Overview
Table 28. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 29. Cadila Pharmaceuticals Mebendazole Product Portfolio
Table 30. Cadila Pharmaceuticals Recent Developments
Table 31. Eipico Company Information
Table 32. Eipico Business Overview
Table 33. Eipico Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 34. Eipico Mebendazole Product Portfolio
Table 35. Eipico Recent Developments
Table 36. Esteve Pharmaceuticals Company Information
Table 37. Esteve Pharmaceuticals Business Overview
Table 38. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 39. Esteve Pharmaceuticals Mebendazole Product Portfolio
Table 40. Esteve Pharmaceuticals Recent Developments
Table 41. Tenry Company Information
Table 42. Tenry Business Overview
Table 43. Tenry Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 44. Tenry Mebendazole Product Portfolio
Table 45. Tenry Recent Developments
Table 46. Global Mebendazole Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 47. Global Mebendazole Sales by Region (2018-2023) & (K Units)
Table 48. Global Mebendazole Sales Market Share by Region (2018-2023)
Table 49. Global Mebendazole Sales by Region (2024-2029) & (K Units)
Table 50. Global Mebendazole Sales Market Share by Region (2024-2029)
Table 51. Global Mebendazole Revenue by Region (2018-2023) & (US$ Million)
Table 52. Global Mebendazole Revenue Market Share by Region (2018-2023)
Table 53. Global Mebendazole Revenue by Region (2024-2029) & (US$ Million)
Table 54. Global Mebendazole Revenue Market Share by Region (2024-2029)
Table 55. North America Mebendazole Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. North America Mebendazole Sales by Country (2018-2023) & (K Units)
Table 57. North America Mebendazole Sales by Country (2024-2029) & (K Units)
Table 58. North America Mebendazole Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Mebendazole Revenue by Country (2024-2029) & (US$ Million)
Table 60. Europe Mebendazole Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. Europe Mebendazole Sales by Country (2018-2023) & (K Units)
Table 62. Europe Mebendazole Sales by Country (2024-2029) & (K Units)
Table 63. Europe Mebendazole Revenue by Country (2018-2023) & (US$ Million)
Table 64. Europe Mebendazole Revenue by Country (2024-2029) & (US$ Million)
Table 65. Asia Pacific Mebendazole Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Asia Pacific Mebendazole Sales by Country (2018-2023) & (K Units)
Table 67. Asia Pacific Mebendazole Sales by Country (2024-2029) & (K Units)
Table 68. Asia Pacific Mebendazole Revenue by Country (2018-2023) & (US$ Million)
Table 69. Asia Pacific Mebendazole Revenue by Country (2024-2029) & (US$ Million)
Table 70. Latin America Mebendazole Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Latin America Mebendazole Sales by Country (2018-2023) & (K Units)
Table 72. Latin America Mebendazole Sales by Country (2024-2029) & (K Units)
Table 73. Latin America Mebendazole Revenue by Country (2018-2023) & (US$ Million)
Table 74. Latin America Mebendazole Revenue by Country (2024-2029) & (US$ Million)
Table 75. Middle East and Africa Mebendazole Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Middle East and Africa Mebendazole Sales by Country (2018-2023) & (K Units)
Table 77. Middle East and Africa Mebendazole Sales by Country (2024-2029) & (K Units)
Table 78. Middle East and Africa Mebendazole Revenue by Country (2018-2023) & (US$ Million)
Table 79. Middle East and Africa Mebendazole Revenue by Country (2024-2029) & (US$ Million)
Table 80. Global Mebendazole Sales by Type (2018-2023) & (K Units)
Table 81. Global Mebendazole Sales by Type (2024-2029) & (K Units)
Table 82. Global Mebendazole Sales Market Share by Type (2018-2023)
Table 83. Global Mebendazole Sales Market Share by Type (2024-2029)
Table 84. Global Mebendazole Revenue by Type (2018-2023) & (US$ Million)
Table 85. Global Mebendazole Revenue by Type (2024-2029) & (US$ Million)
Table 86. Global Mebendazole Revenue Market Share by Type (2018-2023)
Table 87. Global Mebendazole Revenue Market Share by Type (2024-2029)
Table 88. Global Mebendazole Price by Type (2018-2023) & (USD/Unit)
Table 89. Global Mebendazole Price by Type (2024-2029) & (USD/Unit)
Table 90. Global Mebendazole Sales by Application (2018-2023) & (K Units)
Table 91. Global Mebendazole Sales by Application (2024-2029) & (K Units)
Table 92. Global Mebendazole Sales Market Share by Application (2018-2023)
Table 93. Global Mebendazole Sales Market Share by Application (2024-2029)
Table 94. Global Mebendazole Revenue by Application (2018-2023) & (US$ Million)
Table 95. Global Mebendazole Revenue by Application (2024-2029) & (US$ Million)
Table 96. Global Mebendazole Revenue Market Share by Application (2018-2023)
Table 97. Global Mebendazole Revenue Market Share by Application (2024-2029)
Table 98. Global Mebendazole Price by Application (2018-2023) & (USD/Unit)
Table 99. Global Mebendazole Price by Application (2024-2029) & (USD/Unit)
Table 100. Key Raw Materials
Table 101. Raw Materials Key Suppliers
Table 102. Mebendazole Distributors List
Table 103. Mebendazole Customers List
Table 104. Mebendazole Industry Trends
Table 105. Mebendazole Industry Drivers
Table 106. Mebendazole Industry Restraints
Table 107. Authors 12. List of This Report

LIST OF FIGURES

Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. MebendazoleProduct Picture
Figure 5. Global Mebendazole Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Mebendazole Market Size (2018-2029) & (US$ Million)
Figure 7. Global Mebendazole Sales (2018-2029) & (K Units)
Figure 8. Global Mebendazole Average Price (USD/Unit) & (2018-2029)
Figure 9. Tablet Product Picture
Figure 10. Oral Suspension Product Picture
Figure 11. Below 2 Years Old Product Picture
Figure 12. Above 2 Years Old Product Picture
Figure 13. Global Mebendazole Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Mebendazole, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Mebendazole, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Mebendazole Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Mebendazole Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Mebendazole Sales by Region in 2022
Figure 20. Global Mebendazole Revenue by Region in 2022
Figure 21. North America Mebendazole Market Size by Country in 2022
Figure 22. North America Mebendazole Sales Market Share by Country (2018-2029)
Figure 23. North America Mebendazole Revenue Market Share by Country (2018-2029)
Figure 24. United States Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Mebendazole Market Size by Country in 2022
Figure 27. Europe Mebendazole Sales Market Share by Country (2018-2029)
Figure 28. Europe Mebendazole Revenue Market Share by Country (2018-2029)
Figure 29. Germany Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Mebendazole Market Size by Country in 2022
Figure 35. Asia Pacific Mebendazole Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Mebendazole Revenue Market Share by Country (2018-2029)
Figure 37. China Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Mebendazole Market Size by Country in 2022
Figure 47. Latin America Mebendazole Sales Market Share by Country (2018-2029)
Figure 48. Latin America Mebendazole Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa Mebendazole Market Size by Country in 2022
Figure 53. Middle East and Africa Mebendazole Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa Mebendazole Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Mebendazole Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Mebendazole Sales Market Share by Type (2018-2029)
Figure 59. Global Mebendazole Revenue Market Share by Type (2018-2029)
Figure 60. Global Mebendazole Price (USD/Unit) by Type (2018-2029)
Figure 61. Global Mebendazole Sales Market Share by Application (2018-2029)
Figure 62. Global Mebendazole Revenue Market Share by Application (2018-2029)
Figure 63. Global Mebendazole Price (USD/Unit) by Application (2018-2029)
Figure 64. Mebendazole Value Chain
Figure 65. Mebendazole Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Mebendazole Industry Opportunities and Challenges


More Publications